Compile Data Set for Download or QSAR
maximum 50k data
Found 43 Enz. Inhib. hit(s) with all data for entry = 5851
TargetSubstance-P receptor(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM97478(US8470816, 91)
Affinity DataIC50:  0.0920nMpH: 7.4Assay Description:Radioligan receptor binding inhibitory activity using membrane fraction of CHO cell expressing human NK receptors.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSubstance-K receptor(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM97486(US8470816, 464)
Affinity DataIC50:  0.220nMpH: 7.5Assay Description:Radioligan receptor binding inhibitory activity using membrane fraction of CHO cell expressing human NK receptors.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSubstance-K receptor(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM97485(US8470816, 458)
Affinity DataIC50:  0.220nMpH: 7.5Assay Description:Radioligan receptor binding inhibitory activity using membrane fraction of CHO cell expressing human NK receptors.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSubstance-K receptor(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM97489(US8470816, 632)
Affinity DataIC50:  0.220nMpH: 7.5Assay Description:Radioligan receptor binding inhibitory activity using membrane fraction of CHO cell expressing human NK receptors.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSubstance-K receptor(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM97481(US8470816, 265)
Affinity DataIC50:  0.230nMpH: 7.5Assay Description:Radioligan receptor binding inhibitory activity using membrane fraction of CHO cell expressing human NK receptors.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSubstance-K receptor(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM97490(US8470816, 633)
Affinity DataIC50:  0.240nMpH: 7.5Assay Description:Radioligan receptor binding inhibitory activity using membrane fraction of CHO cell expressing human NK receptors.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSubstance-K receptor(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM97483(US8470816, 292)
Affinity DataIC50:  0.25nMpH: 7.5Assay Description:Radioligan receptor binding inhibitory activity using membrane fraction of CHO cell expressing human NK receptors.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSubstance-K receptor(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM97479(US8470816, 251a)
Affinity DataIC50:  0.310nMpH: 7.5Assay Description:Radioligan receptor binding inhibitory activity using membrane fraction of CHO cell expressing human NK receptors.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSubstance-K receptor(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM97487(US8470816, 623)
Affinity DataIC50:  0.310nMpH: 7.5Assay Description:Radioligan receptor binding inhibitory activity using membrane fraction of CHO cell expressing human NK receptors.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSubstance-K receptor(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM97491(US8470816, 635)
Affinity DataIC50:  0.360nMpH: 7.5Assay Description:Radioligan receptor binding inhibitory activity using membrane fraction of CHO cell expressing human NK receptors.More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSubstance-K receptor(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM97482(US8470816, 268)
Affinity DataIC50:  0.420nMpH: 7.5Assay Description:Radioligan receptor binding inhibitory activity using membrane fraction of CHO cell expressing human NK receptors.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSubstance-K receptor(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM97472(US8470816, 18)
Affinity DataIC50:  0.450nMpH: 7.5Assay Description:Radioligan receptor binding inhibitory activity using membrane fraction of CHO cell expressing human NK receptors.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSubstance-K receptor(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM97488(US8470816, 629)
Affinity DataIC50:  0.550nMpH: 7.5Assay Description:Radioligan receptor binding inhibitory activity using membrane fraction of CHO cell expressing human NK receptors.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSubstance-K receptor(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM97480(US8470816, 252)
Affinity DataIC50:  0.560nMpH: 7.5Assay Description:Radioligan receptor binding inhibitory activity using membrane fraction of CHO cell expressing human NK receptors.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSubstance-K receptor(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM97478(US8470816, 91)
Affinity DataIC50:  0.790nMpH: 7.5Assay Description:Radioligan receptor binding inhibitory activity using membrane fraction of CHO cell expressing human NK receptors.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSubstance-K receptor(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM97484(US8470816, 318)
Affinity DataIC50:  0.820nMpH: 7.5Assay Description:Radioligan receptor binding inhibitory activity using membrane fraction of CHO cell expressing human NK receptors.More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSubstance-K receptor(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM97475(US8470816, 30)
Affinity DataIC50:  1.10nMpH: 7.5Assay Description:Radioligan receptor binding inhibitory activity using membrane fraction of CHO cell expressing human NK receptors.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSubstance-P receptor(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM97477(US8470816, 82)
Affinity DataIC50:  1.5nMpH: 7.4Assay Description:Radioligan receptor binding inhibitory activity using membrane fraction of CHO cell expressing human NK receptors.More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSubstance-K receptor(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM97476(US8470816, 31)
Affinity DataIC50:  1.70nMpH: 7.5Assay Description:Radioligan receptor binding inhibitory activity using membrane fraction of CHO cell expressing human NK receptors.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSubstance-K receptor(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM97474(US8470816, 24)
Affinity DataIC50:  2nMpH: 7.5Assay Description:Radioligan receptor binding inhibitory activity using membrane fraction of CHO cell expressing human NK receptors.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSubstance-K receptor(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM97477(US8470816, 82)
Affinity DataIC50:  2.20nMpH: 7.5Assay Description:Radioligan receptor binding inhibitory activity using membrane fraction of CHO cell expressing human NK receptors.More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSubstance-K receptor(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM97473(US8470816, 21)
Affinity DataIC50:  2.30nMpH: 7.5Assay Description:Radioligan receptor binding inhibitory activity using membrane fraction of CHO cell expressing human NK receptors.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTachykinin-3(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM97475(US8470816, 30)
Affinity DataIC50:  23nMpH: 7.4Assay Description:Radioligan receptor binding inhibitory activity using membrane fraction of CHO cell expressing human NK receptors.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTachykinin-3(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM97472(US8470816, 18)
Affinity DataIC50:  24nMpH: 7.4Assay Description:Radioligan receptor binding inhibitory activity using membrane fraction of CHO cell expressing human NK receptors.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTachykinin-3(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM97474(US8470816, 24)
Affinity DataIC50:  49nMpH: 7.4Assay Description:Radioligan receptor binding inhibitory activity using membrane fraction of CHO cell expressing human NK receptors.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSubstance-P receptor(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM97483(US8470816, 292)
Affinity DataIC50:  62nMpH: 7.4Assay Description:Radioligan receptor binding inhibitory activity using membrane fraction of CHO cell expressing human NK receptors.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSubstance-P receptor(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM97472(US8470816, 18)
Affinity DataIC50:  67nMpH: 7.4Assay Description:Radioligan receptor binding inhibitory activity using membrane fraction of CHO cell expressing human NK receptors.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSubstance-P receptor(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM97479(US8470816, 251a)
Affinity DataIC50:  78nMpH: 7.4Assay Description:Radioligan receptor binding inhibitory activity using membrane fraction of CHO cell expressing human NK receptors.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSubstance-P receptor(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM97485(US8470816, 458)
Affinity DataIC50:  79nMpH: 7.4Assay Description:Radioligan receptor binding inhibitory activity using membrane fraction of CHO cell expressing human NK receptors.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSubstance-P receptor(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM97481(US8470816, 265)
Affinity DataIC50:  80nMpH: 7.4Assay Description:Radioligan receptor binding inhibitory activity using membrane fraction of CHO cell expressing human NK receptors.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSubstance-P receptor(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM97490(US8470816, 633)
Affinity DataIC50:  84nMpH: 7.4Assay Description:Radioligan receptor binding inhibitory activity using membrane fraction of CHO cell expressing human NK receptors.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTachykinin-3(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM97473(US8470816, 21)
Affinity DataIC50:  130nMpH: 7.4Assay Description:Radioligan receptor binding inhibitory activity using membrane fraction of CHO cell expressing human NK receptors.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSubstance-P receptor(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM97489(US8470816, 632)
Affinity DataIC50:  140nMpH: 7.4Assay Description:Radioligan receptor binding inhibitory activity using membrane fraction of CHO cell expressing human NK receptors.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTachykinin-3(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM97476(US8470816, 31)
Affinity DataIC50:  160nMpH: 7.4Assay Description:Radioligan receptor binding inhibitory activity using membrane fraction of CHO cell expressing human NK receptors.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSubstance-P receptor(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM97486(US8470816, 464)
Affinity DataIC50:  220nMpH: 7.4Assay Description:Radioligan receptor binding inhibitory activity using membrane fraction of CHO cell expressing human NK receptors.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSubstance-P receptor(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM97475(US8470816, 30)
Affinity DataIC50:  240nMpH: 7.4Assay Description:Radioligan receptor binding inhibitory activity using membrane fraction of CHO cell expressing human NK receptors.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSubstance-P receptor(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM97480(US8470816, 252)
Affinity DataIC50:  250nMpH: 7.4Assay Description:Radioligan receptor binding inhibitory activity using membrane fraction of CHO cell expressing human NK receptors.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSubstance-P receptor(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM97474(US8470816, 24)
Affinity DataIC50:  260nMpH: 7.4Assay Description:Radioligan receptor binding inhibitory activity using membrane fraction of CHO cell expressing human NK receptors.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSubstance-P receptor(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM97473(US8470816, 21)
Affinity DataIC50:  330nMpH: 7.4Assay Description:Radioligan receptor binding inhibitory activity using membrane fraction of CHO cell expressing human NK receptors.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTachykinin-3(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM97478(US8470816, 91)
Affinity DataIC50:  330nMpH: 7.4Assay Description:Radioligan receptor binding inhibitory activity using membrane fraction of CHO cell expressing human NK receptors.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSubstance-P receptor(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM97476(US8470816, 31)
Affinity DataIC50:  410nMpH: 7.4Assay Description:Radioligan receptor binding inhibitory activity using membrane fraction of CHO cell expressing human NK receptors.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSubstance-P receptor(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM97484(US8470816, 318)
Affinity DataIC50:  520nMpH: 7.4Assay Description:Radioligan receptor binding inhibitory activity using membrane fraction of CHO cell expressing human NK receptors.More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSubstance-P receptor(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM97491(US8470816, 635)
Affinity DataIC50:  1.10E+3nMpH: 7.4Assay Description:Radioligan receptor binding inhibitory activity using membrane fraction of CHO cell expressing human NK receptors.More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent